Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Income from Continuing Operations (2016 - 2025)

INVO Fertility (IVF) has disclosed Income from Continuing Operations for 15 consecutive years, with 2644625.0 as the latest value for Q3 2025.

  • Quarterly Income from Continuing Operations fell 62.18% to 2644625.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 26880798.0 through Sep 2025, down 259.95% year-over-year, with the annual reading at 9095838.0 for FY2024, 13.2% down from the prior year.
  • Income from Continuing Operations for Q3 2025 was 2644625.0 at INVO Fertility, up from 3209094.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 101782.0 in Q4 2021, with the low at 17403586.0 in Q1 2025.
  • Average Income from Continuing Operations over 5 years is 3045218.89, with a median of 2481326.0 recorded in 2021.
  • The sharpest move saw Income from Continuing Operations skyrocketed 102.67% in 2021, then crashed 2818.59% in 2022.
  • Over 5 years, Income from Continuing Operations stood at 101782.0 in 2021, then plummeted by 2818.59% to 2767035.0 in 2022, then rose by 27.88% to 1995642.0 in 2023, then tumbled by 81.57% to 3623493.0 in 2024, then increased by 27.01% to 2644625.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 2644625.0, 3209094.0, and 17403586.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.